PT  - JOURNAL ARTICLE
AU  - Hüseyin Aksoy
AU  - Ülkü Aksoy
AU  - Sezin Ozyurt
AU  - Gökhan Açmaz
AU  - Mustafa Babayigit
TI  - Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial
AID  - 10.1136/jfprhc-2014-100917
DP  - 2016 Apr 01
TA  - Journal of Family Planning and Reproductive Health Care
PG  - 83--87
VI  - 42
IP  - 2
4099  - http://jfprhc.bmj.com/content/42/2/83.short
4100  - http://jfprhc.bmj.com/content/42/2/83.full
SO  - J Fam Plann Reprod Health Care2016 Apr 01; 42
AB  - Objective Fear of pain during intrauterine device (IUD) insertion can be a barrier to widespread use of this safe and highly effective contraceptive method. Our objective was to determine the effectiveness of topical 10% lidocaine spray for pain control during IUD insertion.Methods A total of 200 subjects with the request for IUD insertion were included in the study. The patients were randomly divided into two groups: lidocaine spray (n=100) and placebo (n=100). The pain experienced during the procedure was measured immediately after insertion by a standard Visual Analogue Scale (VAS) administered by a separate researcher with maintenance of allocation concealment.Results The mean pain score during the procedure was 1.01±1.20 in the lidocaine spray group and 3.23±1.60 in the placebo spray group (p<0.001). Lidocaine spray treatment significantly lowered the overall procedural pain score compared with placebo.Conclusions Significant pain reduction during IUD insertion can be achieved by using 10% lidocaine spray alone. Lidocaine spray can be accepted as a non-invasive, easy to apply and more comfortable local anaesthetic method for IUD insertion.Trial registration number NCT02020551.